✦ LIBER ✦

Interleukin-6, a new target for therapy in multiple myeloma?

✍ Scribed by M. H. J. van Oers; H. C. T. van Zaanen; H. M. Lokhorst

Publisher: Springer
Year: 1993
Tongue: English
Weight: 550 KB
Volume: 66
Category: Article
ISSN: 0939-5555
DOI: 10.1007/bf01738469

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-1 and interleukin-6 producti

Interleukin-1 and interleukin-6 production in peripheral blood and bone marrow mononuclear cell culture in multiple myeloma

✍ E. N. Klyushnenkova; T. D. Lutskaya; A. K. Golenkov; V. V. Malaitsev 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 393 KB

Targeting the interleukin-6 receptor: A

Targeting the interleukin-6 receptor: A new treatment for systemic juvenile idiopathic arthritis?

✍ Fabrizio de Benedetti; Alberto Martini 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

Interferon-α: A new target for therapy i

Interferon-α: A new target for therapy in systemic lupus erythematosus?

✍ Mary K. Crow 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB 👁 1 views

Interferon-β therapy for multiple sclero

Interferon-β therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production

✍ Adriana A. Byrnes; Justin C. McArthur; Christopher L. Karp 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 1 views

## Abstract Interleukin–12 is critical to the pathogenesis of experimental autoimmune encephalomyelitis in multiple species. Interleukin‐10, a dominant endogenous inhibitor of interleukin‐12, is largely protective in these experimental surrogates for multiple sclerosis. Such data have suggested tha

Serum levels of interleukin-6 in multipl

Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters

✍ D. M. Nachbaur; M. Herold; A. Maneschg; H. Huber 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 499 KB

Does vascular endothelial growth factor

Does vascular endothelial growth factor play a role in interleukin-6 receptor antagonist therapy for rheumatoid arthritis?

✍ Julieta Gentiletti; Roy A. Fava 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views